Attention Deficit Disorder with Hyperactivity (ADHD)ADHDNCT06743542
Assessment of Handwriting Skills in a Sample of Egyptian Children with Attention-Deficit Hyperactivity Disorder
An observational study of Attention Deficit Disorder with Hyperactivity (ADHD), run by October 6 University at 1 site in Egypt.
Trial summary
PURPOSE: To assess handwriting difficulties in ADHD children. BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders that affects 7.6% of children worldwide. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Attention Deficit Disorder with Hyperactivity (ADHD)
- How many people
- 70 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Mar 2024to 15 Nov 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: ADHD children can read and write both sexes.
Who may be able to join
- ADHD children can read and write
- both sexes.
Who cannot join
- low IQ children
Trial locations and contacts
1 site in 1 country.
About this study
PURPOSE: To assess handwriting difficulties in ADHD children. BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders that affects 7.6% of children worldwide. In addition to the core symptoms defining Attention-Deficit/Hyperactivity Disorder (ADHD), ADHD children often experience motor problems, including graphomotor movements, leading to handwriting difficulties. Studies have confirmed that handwriting skills are adversely impacted by the presence of ADHD, and this is associated with lower academic achievement and self-esteem. Children with ADHD have been found to display greater difficulties in the development of motor coordination, especially in the planning and execution of complex, lengthy, and novel chains of goal-directed behavior. Also, handwriting problems in ADHD may signal underlying executive function deficits such as inhibition, emotional dysregulation, working memory problems, and difficulty with self-monitoring, all of which are required for various daily functions beyond handwriting per se. With a slower motor response and perceptual speed, these deficits may decrease the likelihood that a child with ADHD can work efficiently and stay on-task during school and home activities.
Read the detailed description
Written informed consents will be obtained from the parents of participants. All participants will undergo the following:
- Thorough history taking and medical examination.
- Anthropometric measurements: weight, height
- Diagnosis by DSM 5
- Conners' Parent Rating Scales-Revised (CPRS-R) to assess the severity of ADHD symptoms.
- Intelligence quotient (IQ) test: Stanford Binet intelligence scale, fifth edition to assess the mental ages of the children and measure their intelligence quotients.
- Assessment of handwriting using (Handwriting Legibility Scale (HLS) to evaluate the handwriting skills of the participants including ……
- Assessment of neuropsychological abilities related to executive functioning and learning Using the Learning, Executive, and Attention Functioning (Leaf) scale.
- Language assessment to identify any underlying language deficits that might contribute to handwriting difficulties.
- A Baseline mechanical gauge was used to measure palmer pinch strength in kilograms
- A Baseline mechanical gauge was used to measure hand grip strength in kilograms
- Statistical analysis using the SPSS version 22.
- Keywords
- ADHD, Handwriting skills
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What is being measured
The primary outcome is the main question the study is designed to answer.
Handwriting Skills
Measured: 3 monthe
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Dec 2024
- Study start15 Mar 2024
- Primary completion15 Sep 2024
- Study completion15 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention Deficit Disorder with Hyperactivity (ADHD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- October 6 University
- Sponsor type
- University, hospital or other
- Collaborators
- National Research Centre, Egypt
- Responsible party
- Principal investigator, Walid Saber Hussain, October 6 University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06743542
- Sponsor's protocol ID
- o6u
- Other IDs
- Assessment of Handwriting Skil
- Acronym
- ADHD
- Status last verified
- Dec 2024
- First submitted
- 25 Oct 2024
- Last updated
- 20 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 20 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Handwriting Skills in a Sample of Egyptian Children with Attention-Deficit Hyperactivity Disorder
- ClinicalTrials.gov ID
- NCT06743542
- Acronym / sponsor ID
- ADHD / o6u
- Keywords
- ADHD, Handwriting skills
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- October 6 UniversityUniversity, hospital or other
- Collaborators
- National Research Centre, Egypt
- Study start
- 15 Mar 2024 (actual)
- Primary completion
- 15 Sep 2024 (actual)
- Study completion
- 15 Nov 2024 (actual)
- First posted
- 20 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
PURPOSE: To assess handwriting difficulties in ADHD children. BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders that affects 7.6% of children worldwide. In addition to the core symptoms defining Attention-Deficit/Hyperactivity Disorder (ADHD), ADHD children often experience motor problems, including graphomotor movements, leading to handwriting difficulties. Studies have confirmed that handwriting skills are adversely impacted by the presence of ADHD, and this is associated with lower academic achievement and self-esteem. Children with ADHD have been found to display greater difficulties in the development of motor coordination, especially in the planning and execution of complex, lengthy, and novel chains of goal-directed behavior. Also, handwriting problems in ADHD may signal underlying executive function deficits such as inhibition, emotional dysregulation, working memory problems, and difficulty with self-monitoring, all of which are required for various daily functions beyond handwriting per se. With a slower motor response and perceptual speed, these deficits may decrease the likelihood that a child with ADHD can work efficiently and stay on-task during school and home activities.
Detailed description
Written informed consents will be obtained from the parents of participants. All participants will undergo the following:
- Thorough history taking and medical examination.
- Anthropometric measurements: weight, height
- Diagnosis by DSM 5
- Conners' Parent Rating Scales-Revised (CPRS-R) to assess the severity of ADHD symptoms.
- Intelligence quotient (IQ) test: Stanford Binet intelligence scale, fifth edition to assess the mental ages of the children and measure their intelligence quotients.
- Assessment of handwriting using (Handwriting Legibility Scale (HLS) to evaluate the handwriting skills of the participants including ……
- Assessment of neuropsychological abilities related to executive functioning and learning Using the Learning, Executive, and Attention Functioning (Leaf) scale.
- Language assessment to identify any underlying language deficits that might contribute to handwriting difficulties.
- A Baseline mechanical gauge was used to measure palmer pinch strength in kilograms
- A Baseline mechanical gauge was used to measure hand grip strength in kilograms
- Statistical analysis using the SPSS version 22.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- ADHD children can read and write both sexes.
Key inclusion criteria (2 listed)
- ADHD children can read and write
- both sexes.
Key exclusion criteria (1 listed)
- low IQ children
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Handwriting Skills
Time frame: 3 monthe
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Dec 2024.
Related trials for Attention Deficit Disorder with Hyperactivity (ADHD)
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
ADHD
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
AI-assisted Home-based Intervention for ADHD Children
ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type
Recruiting
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Attention Deficit Disorder with Hyperactivity (ADHD), run by October 6 University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Handwriting Skills (time frame: 3 monthe). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2024; AzTrials last refreshed its copy on 8 Nov 2026.